全文获取类型
收费全文 | 7847篇 |
免费 | 658篇 |
国内免费 | 6篇 |
专业分类
8511篇 |
出版年
2023年 | 28篇 |
2022年 | 81篇 |
2021年 | 122篇 |
2020年 | 63篇 |
2019年 | 109篇 |
2018年 | 153篇 |
2017年 | 113篇 |
2016年 | 237篇 |
2015年 | 363篇 |
2014年 | 424篇 |
2013年 | 436篇 |
2012年 | 551篇 |
2011年 | 559篇 |
2010年 | 348篇 |
2009年 | 328篇 |
2008年 | 450篇 |
2007年 | 433篇 |
2006年 | 393篇 |
2005年 | 396篇 |
2004年 | 399篇 |
2003年 | 349篇 |
2002年 | 313篇 |
2001年 | 303篇 |
2000年 | 242篇 |
1999年 | 214篇 |
1998年 | 76篇 |
1997年 | 79篇 |
1996年 | 58篇 |
1995年 | 57篇 |
1994年 | 37篇 |
1993年 | 27篇 |
1992年 | 77篇 |
1991年 | 83篇 |
1990年 | 50篇 |
1989年 | 54篇 |
1988年 | 46篇 |
1987年 | 44篇 |
1986年 | 32篇 |
1985年 | 35篇 |
1984年 | 33篇 |
1982年 | 20篇 |
1981年 | 17篇 |
1979年 | 19篇 |
1978年 | 22篇 |
1977年 | 23篇 |
1976年 | 24篇 |
1974年 | 24篇 |
1973年 | 19篇 |
1971年 | 20篇 |
1970年 | 17篇 |
排序方式: 共有8511条查询结果,搜索用时 15 毫秒
101.
Yeon-Jeong Kim Jong-Hoon Park Koung-Sook Kim Ji-Eun Chang Jeong Heon Ko Myung-Hee Kim Dong-Hyo Chung Tae-Wha Chung In-Seong Choe Young-Choon Lee Cheorl-Ho Kim 《Gene》1996,170(2):281-283
We have isolated and characterized the immediate (1651 bp) 5′-flanking region of the gene (GnT-III) encoding N-acetylglucosaminyltransferase III (GnT-III) from a human placental genomic library. Analysis of promoter elements shows a similarity to the 5′-flanking region of murine 1,4-galactosyltransferase. The sequence lacks obvious TATA elements and CCAAT boxes; however, putative regulatory sites, including 2 potential cAMP-response regulatory elements (CRE), 11 insulin-response element consensus sequences (IRE), 7 potential AP-2-binding sites, 2 SP1 consensus sequences (GC boxes) and 2 sequences similar to the half-palindromic glucocorticoid-responsive element (GRE), are present. 相似文献
102.
103.
104.
105.
Geetha Nalairndran Ivy Chung Azad Hassan Abdul Razack Felicia Fei-Lei Chung Ling-Wei Hii Wei-Meng Lim Chin King Looi Chun-Wai Mai Chee-Onn Leong 《Journal of cellular and molecular medicine》2021,25(17):8187-8200
Prostate cancer (PCa) is the second most common malignancy and is the fifth leading cause of cancer mortality among men globally. Docetaxel-based therapy remains the first-line treatment for metastatic castration-resistant prostate cancer. However, dose-limiting toxicity including neutropenia, myelosuppression and neurotoxicity is the major reason for docetaxel dose reductions and fewer cycles administered, despite a recent study showing a clear survival benefit with increased total number of docetaxel cycles in PCa patients. Although previous studies have attempted to improve the efficacy and reduce docetaxel toxicity through drug combination, no drug has yet demonstrated improved overall survival in clinical trial, highlighting the challenges of improving the activity of docetaxel monotherapy in PCa. Herein, we identified 15 lethality hits for which inhibition could enhance docetaxel sensitivity in PCa cells via a high-throughput kinome-wide loss-of-function screen. Further drug-gene interactions analyses identified Janus kinase 1 (JAK1) as a viable druggable target with existing experimental inhibitors and FDA-approved drugs. We demonstrated that depletion of endogenous JAK1 enhanced docetaxel-induced apoptosis in PCa cells. Furthermore, inhibition of JAK1/2 by baricitinib and ruxolitinib synergizes docetaxel sensitivity in both androgen receptor (AR)–negative DU145 and PC3 cells, but not in the AR-positive LNCaP cells. In contrast, no synergistic effects were observed in cells treated with JAK2-specific inhibitor, fedratinib, suggesting that the synergistic effects are mainly mediated through JAK1 inhibition. In conclusion, the combination therapy with JAK1 inhibitors and docetaxel could be a useful therapeutic strategy in the treatment of prostate cancers. 相似文献
106.
Wang Shih-Wei Chung Chih-Ling Yu-Chen Kao René Martin Hans-Joachim Knölker Meng-Shin Shiao 《Journal of enzyme inhibition and medicinal chemistry》2018,33(1):920-935
Pentabromopseudilin (PBrP) is a marine antibiotic isolated from the marine bacteria Pseudomonas bromoutilis and Alteromonas luteoviolaceus. PBrP exhibits antimicrobial, anti-tumour, and phytotoxic activities. In mammalian cells, PBrP is known to act as a reversible and allosteric inhibitor of myosin Va (MyoVa). In this study, we report that PBrP is a potent inhibitor of transforming growth factor-β (TGF-β) activity. PBrP inhibits TGF-β-stimulated Smad2/3 phosphorylation, plasminogen activator inhibitor-1 (PAI-1) protein production and blocks TGF-β-induced epithelial–mesenchymal transition in epithelial cells. PBrP inhibits TGF-β signalling by reducing the cell-surface expression of type II TGF-β receptor (TβRII) and promotes receptor degradation. Gene silencing approaches suggest that MyoVa plays a crucial role in PBrP-induced TβRII turnover and the subsequent reduction of TGF-β signalling. Because, TGF-β signalling is crucial in the regulation of diverse pathophysiological processes such as tissue fibrosis and cancer development, PBrP should be further explored for its therapeutic role in treating fibrotic diseases and cancer. 相似文献
107.
You stay,but I Hop: Host shifting near and far co‐dominated the evolution of Enchenopa treehoppers 下载免费PDF全文
Yu‐Hsun Hsu Reginald B. Cocroft Robert L. Snyder Chung‐Ping Lin 《Ecology and evolution》2018,8(4):1954-1965
The importance and prevalence of phylogenetic tracking between hosts and dependent organisms caused by co‐evolution and shifting between closely related host species have been debated for decades. Most studies of phylogenetic tracking among phytophagous insects and their host plants have been limited to insects feeding on a narrow range of host species. However, narrow host ranges can confound phylogenetic tracking (phylogenetic tracking hypothesis) with host shifting between hosts of intermediate relationship (intermediate hypothesis). Here, we investigated the evolutionary history of the Enchenopa binotata complex of treehoppers. Each species in this complex has high host fidelity, but the entire complex uses hosts across eight plant orders. The phylogenies of E. binotata were reconstructed to evaluate whether (1) tracking host phylogeny; or (2) shifting between intermediately related host plants better explains the evolutionary history of E. binotata. Our results suggest that E. binotata primarily shifted between both distant and intermediate host plants regardless of host phylogeny and less frequently tracked the phylogeny of their hosts. These findings indicate that phytophagous insects with high host fidelity, such as E. binotata, are capable of adaptation not only to closely related host plants but also to novel hosts, likely with diverse phenology and defense mechanisms. 相似文献
108.
Jeong JH Jeong YJ Cho HJ Shin JM Kang JH Park KK Park YY Chung IK Chang HW Magae J 《Journal of cellular biochemistry》2012,113(4):1302-1313
Ascochlorin, a non-toxic prenylphenol compound derived from the fungus Ascochyta viciae, has been shown recently to have anti-cancer effects on various human cancer cells. However, the precise molecular mechanism of this anti-cancer activity remains to be elucidated. Here, we investigated the effects of ascochlorin on hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) expression in human epidermoid cervical carcinoma CaSki cells. Ascochlorin inhibited epidermal growth factor (EGF)-induced HIF-1α and VEGF expression through multiple potential mechanisms. First, ascochlorin selectively inhibited HIF-1α expression in response to EGF stimulation, but not in response to hypoxia (1% O(2)) or treatment with a transition metal (CoCl(2)). Second, ascochlorin inhibited EGF-induced ERK-1/2 activation but not AKT activation, both of which play essential roles in EGF-induced HIF-1α protein synthesis. Targeted inhibition of epidermal growth factor receptor (EGFR) expression using an EGFR-specific small interfering RNA (siRNA) diminished HIF-1α expression, which suggested that ascochlorin inhibits HIF-1α expression through suppression of EGFR activation. Finally, we showed that ascochlorin functionally abrogates in vivo tumor angiogenesis induced by EGF in a Matrigel plug assay. Our data suggest that ascochlorin inhibits EGF-mediated induction of HIF-1α expression in CaSki cells, providing a potentially new avenue of development of anti-cancer drugs that target tumor angiogenesis. 相似文献
109.
110.
Kim M Lee JH Koh H Lee SY Jang C Chung CJ Sung JH Blenis J Chung J 《The EMBO journal》2006,25(13):3056-3067
Although p90 ribosomal S6 kinase (RSK) is known as an important downstream effector of the ribosomal protein S6 kinase/extracellular signal-regulated kinase (Ras/ERK) pathway, its endogenous role, and precise molecular function remain unclear. Using gain-of-function and null mutants of RSK, its physiological role was successfully characterized in Drosophila. Surprisingly, RSK-null mutants were viable, but exhibited developmental abnormalities related to an enhanced ERK-dependent cellular differentiation such as ectopic photoreceptor- and vein-cell formation. Conversely, overexpression of RSK dramatically suppressed the ERK-dependent differentiation, which was further augmented by mutations in the Ras/ERK pathway. Consistent with these physiological phenotypes, RSK negatively regulated ERK-mediated developmental processes and gene expressions by blocking the nuclear localization of ERK in a kinase activity-independent manner. In addition, we further demonstrated that the RSK-dependent inhibition of ERK nuclear migration is mediated by the physical association between ERK and RSK. Collectively, our study reveals a novel regulatory mechanism of the Ras/ERK pathway by RSK, which negatively regulates ERK activity by acting as a cytoplasmic anchor in Drosophila. 相似文献